Delivery Order SPE2DB22D3016-SPE2DB25FBHS2
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order for AZSTARYS Capsules (39.2mg/7.8mg) valued at $1,567.95 by the Defense Department's Medical Supply Chain division. This competitively awarded, non-set-aside contract is priced on a firm fixed-price basis with a completion date of June 3, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations as a major healthcare...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,668.99 on August 18, 2025, for the supply of Azstarys 52.3 mg-10.4 mg capsules (100-count unit). This firm fixed-price contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 19, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, reflecting the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,521.90 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. The delivery order, issued under a firm fixed price contract type, covers the supply of ADZENYS XR ODT Tablets 1's 6.3MG, a prescription medication used in the treatment of attention-deficit/hyperactivity disorder....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,590.98 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, issued on June 18, 2025, with an ultimate completion date of July 11, 2025, represents a competitively awarded, non-set-aside contract. This award falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,212.00 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract is firm fixed-price with an ultimate completion date of July 29, 2025, and represents a non-competitive, non-set-aside award. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $1,173.52 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025. This firm fixed-price delivery order, which represents a child award under a larger contract vehicle, carries an ultimate completion date of August 13, 2025. The contract was competitively awarded with no set-aside designation and utilizes...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,093.88 by the Defense Logistics Agency's Medical Supply Chain on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,983.52 by the Defense Logistics Agency's Medical Supply Chain on August 16, 2025, with an ultimate completion date of August 18, 2025. This contract represents a firm fixed price delivery order under a competitive procurement with no set-aside designation. The award is a child contract issued under AmerisourceBergen's significant Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $140,578.74 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHS2Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,034.80 by the Defense Logistics Agency (DLA) on September 9, 2025, with completion expected by September 10, 2025. The contract, issued under a firm fixed-price arrangement with no set-aside designation, calls for the delivery of Azstarys 39.2 mg-7.8 mg capsules (100-count units), a prescription medication used to treat attention-deficit/hyperactivity disorder. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The award reflects AmerisourceBergen's established role as a critical vendor within the Defense Health Agency's pharmaceutical supply chain, serving military healthcare systems and other government medical programs worldwide. AmerisourceBergen's federal contracting portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements through competitive procurement processes, with delivery orders typically structured as firm fixed-price arrangements. The company's primary indefinite delivery contract with DLA Troop Support Medical encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains, positioning AmerisourceBergen as a key supplier supporting military readiness and veteran healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/9/25 |